About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT05412680

Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)

Prospective study carried out with ICESP (instituto do Câncer do Estado de São Paulo) patients with thyroid disease with surgical indication

Lead sponsor: Fábio de Aquino Capelli•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Fabio Capelli, phd

CONTACT

55 11 98292-2288 fabiocapelli81@gmail.com

Sponsors

Lead Sponsor

Fábio de Aquino Capelli

Prospective study carried out with ICESP patients with thyroid disease with surgical indication, according to the aforementioned inclusion criteria, totaling 60 cases, which will be randomized into two groups: * Conventional Thyroidectomy (30 patients) * Transoral Endoscopic Thyroidectomy By Vestibular Approach (30 patients)

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•history of hypertrophic scarring and/or motivation to avoid cervical scarring,
•maximum diameter of the thyroid \< 10 cm and of the dominant nodule \< 6 cm,
•estimated thyroid volume \< 45 ml
•benign lesion (multinodular goiter, cyst),
•indeterminate nodule (Bethesda III or IV),
•suspicious nodule for well-differentiated thyroid carcinoma (Bethesda V and VI) \< 2 cm

Exclusion Criteria

•history of previous surgery or irradiation in the head and neck region and superior mediastinum
•evidence of clinical hyperthyroidism
•preoperative recurrent nerve palsy
•lymph node metastasis
•extra-thyroid extension
•plunging goiter
•oral abscess

Related studies

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

NCT01109420 · Non-Medullary Thyroid Cancer

RECRUITINGPhase 3

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

NCT07081997 · Hypoparathyroidism, Endocrine System Diseases, and more

RECRUITINGPhase 4

Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery

NCT07462195 · Thyroid Diseases

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298 · Breast Cancer, NOS, CNS Primary Tumor, NOS, and more

RECRUITINGPhase 2

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

NCT06007924 · Thyroid Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 14, 2024Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment60

Start dateMay 2022

Last updatedMay 14, 2024

Condition

Thyroid Diseases Thyroid Cancer

Locations shown

ICESP

São Paulo, São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 14, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions